Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

2.

Research discovery halts childhood brain tumor before it forms

3.

CAR-T Warning for Secondary Malignancies: Warranted or Not?

4.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

5.

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot